Fig. 2From: A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trialCancer indications under investigation in Phase II and Phase III trials. a Indications are sorted from the most evaluated (left) towards the least (right) using a total of 451 studies. The insert shows the prevalence of studies involving peptide-based or dendritic cell based vaccine in studies completed prior to 2014, or after 2014 (in the 347 studies where completion data was available). b Indications targeted in trials prior to 2014, and after 2014. The % value indicates the percentage contribution for the total number of vaccine trials examinedBack to article page